Pliant Therapeutics Inc (PLRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $43.21M
Last updated: Nov 17, 2026 at 11:06 AM ET
Pliant Therapeutics Inc (PLRX) Competitors
The companies most similar to Pliant Therapeutics are Pelthos Therapeutics (PTHS), Plus Therapeutics (PSTV) and Gain Therapeutics (GANX). By market cap, Pliant Therapeutics ranks 5th of the 13 companies on this page; Rani Therapeutics Holdings (RANI) is the largest at $60.78M.
Peer Comparison
PLRX's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Pliant Therapeutics (PLRX) | $43.21M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Biomea Fusion Inc (BMEA) | $42.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Quince Therapeutics, Inc. (QNCX) | $32.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| Spero Therapeutics Inc (SPRO) | $58.26M | 11.1x | 1.3x | 15.7% | N/A | -95.6% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rani Therapeutics Holdings Inc (RANI) | $60.78M | N/A | 16.3x | 0.0% | N/A | 893.0% | 0.00% |
| Peer median | $41.77M | 11.1x | 7.8x | 0.0% | -133.0% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Pliant Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Biomea Fusion Inc (BMEA) | Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat... | BMEA competitors |
| Quince Therapeutics, Inc. (QNCX) | Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. | |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| Spero Therapeutics Inc (SPRO) | Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing... | SPRO competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Rani Therapeutics Holdings Inc (RANI) | Rani Therapeutics Holdings Inc. is an innovative biotechnology company transforming the landscape of drug delivery with its proprietary RaniPill™ technology... | RANI competitors |
Frequently Asked Questions About PLRX
Who are Pliant Therapeutics' main competitors?
The companies most similar to Pliant Therapeutics include Pelthos Therapeutics (PTHS), Plus Therapeutics (PSTV), Gain Therapeutics (GANX), Biomea Fusion (BMEA) and Quince Therapeutics (QNCX), listed from the closest match.
Who is Pliant Therapeutics' biggest competitor?
Rani Therapeutics Holdings (RANI) is the largest of the similar companies at $60.78M; Pelthos Therapeutics (PTHS) is the closest match by business profile, size, sector and industry.
How does PLRX stock compare with its competitors?
PLRX's net margin is 0.0% against a peer median of 0.0%.
Which of Pliant Therapeutics' competitors pays a higher dividend?
Pliant Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Pliant Therapeutics bigger than its competitors?
No. Pliant Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Rani Therapeutics Holdings (RANI) at $60.78M.
PLRX pages: Overview, Earnings, Forecast, Financials, Competitors